- Home
- LNTH vs DLB Comparison
LNTH vs DLB Comparison
Compare LNTH & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- DLB
- Stock Information
- Founded
- LNTH 1956
- DLB 1965
- Country
- LNTH United States
- DLB United States
- Employees
- LNTH N/A
- DLB N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DLB Multi-Sector Companies
- Sector
- LNTH Health Care
- DLB Miscellaneous
- Exchange
- LNTH Nasdaq
- DLB Nasdaq
- Market Cap
- LNTH 7.5B
- DLB 7.9B
- IPO Year
- LNTH 2015
- DLB 2005
- Fundamental
- Price
- LNTH $75.13
- DLB $75.74
- Analyst Decision
- LNTH Strong Buy
- DLB Strong Buy
- Analyst Count
- LNTH 5
- DLB 4
- Target Price
- LNTH $133.80
- DLB $101.75
- AVG Volume (30 Days)
- LNTH 1.5M
- DLB 384.8K
- Earning Date
- LNTH 05-07-2025
- DLB 05-01-2025
- Dividend Yield
- LNTH N/A
- DLB 1.74%
- EPS Growth
- LNTH N/A
- DLB 36.08
- EPS
- LNTH 3.53
- DLB 2.64
- Revenue
- LNTH $1,536,699,000.00
- DLB $1,320,184,000.00
- Revenue This Year
- LNTH $4.96
- DLB $6.38
- Revenue Next Year
- LNTH $10.25
- DLB $4.65
- P/E Ratio
- LNTH $21.28
- DLB $28.82
- Revenue Growth
- LNTH 12.53
- DLB 4.03
- 52 Week Low
- LNTH $75.00
- DLB $66.35
- 52 Week High
- LNTH $126.89
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- LNTH 27.24
- DLB 48.04
- Support Level
- LNTH $77.01
- DLB $76.69
- Resistance Level
- LNTH $81.50
- DLB $77.59
- Average True Range (ATR)
- LNTH 3.52
- DLB 1.26
- MACD
- LNTH -1.61
- DLB 0.20
- Stochastic Oscillator
- LNTH 0.35
- DLB 57.08
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.